Description
LGD-4033 Ligandrol Injectable Research Overview
Disclaimer: The compounds described on this page are intended for laboratory research use only and are not approved for human consumption.
Overview of LGD-4033 Ligandrol
LGD-4033, also known as Ligandrol, is a nonsteroidal Selective Androgen Receptor Modulator (SARM). It was developed to study its potential in conditions related to muscle loss and impaired bone structure in research models. It has become a well-known SARM because early research shows steady gains in lean mass and good tolerability in test models.
LGD-4033 has shown potential to support muscle development and maintain bone health in research models. Its selective profile engages researchers who are looking for alternatives to broad-acting miscellaneous compounds.
| Section | Details |
|---|---|
| CAS Number | 1165910-22-4 |
| Molar Mass | 338.25 g/mol |
| Chemical Formula | C14H12F6N2O |
| IUPAC Name | 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile [R] |
| Synonyms | LGD-4033, Ligandrol, VK-5211, 1EJT54415A, Vk5211, Ligandrol (LGD-4033), Anabolicum |
| Ingredients / Composition | The key ingredient in LGD-4033 Ligandrol Injectable is Ligandrol with a purity of 99.8%. |
| Shelf Life | 12 to 24 months |
| Storage Instructions | Store LGD-4033 Ligandrol Injectable at a temperature between 20°C and 25 25°C. |
| Disclaimer | LGD-4033 Ligandrol is not approved for human use. It is available for research purposes only. |
LGD-4033 Ligandrol’s Mechanism of Action
LGD-4033 works by selectively binding to androgen receptors in muscle and bone tissue in research models. This interaction mimics certain miscellaneous signals, supports protein synthesis, nitrogen balance, and tissue development in test models. This compound has minimal activity in unrelated areas in subjects.
Why Consider LGD-4033 Ligandrol Injectable for Research?
Researchers may consider LGD-4033 Ligandrol Injectable based on its intended research application, available specifications, and supporting documentation.
- Vendor-reported purity of LGD-4033 Ligandrol Injectable: 99.8%. Review the vendor’s certificate of analysis for the batch.
- The assay result of this product is measured at 98.8%. This confirms consistent concentration for research formulations.
- The appearance of this LGD-4033 injectable is a clear and colorless to pale yellow liquid, which passes visual inspection.
- There is no microbial growth detected, and endotoxin levels are below 0.2 EU/mL.
- The heavy metals are measured at <5 ppm (well within the ≤10 ppm limit).
- The residual solvents in this product are low at 0.1%; water content is maintained at 0.2% (meets USP standards).
- It comes with a complete Certificate of Analysis for validating identity, purity, and compliance with USP testing.
For queries, complaints, or support, please contact help@ironmountainlabz.com
Frequently Asked Questions
Is LGD-4033 SARM legal in the United States?
LGD‑4033 is not legal for human consumption in the United States. The FDA has not approved it as a dietary supplement. However, it is available legally for research purposes in laboratories.
What are the reported effects of LGD-4033 in research models
Research suggests that LGD-4033 can increase lean muscle mass without significantly affecting fat mass in research models. It also seems to promote bone growth and strength in test models.
What is the half-life of LGD-4033 in test models?
There is limited data available that reports the elimination half‑life of LGD‑4033 after injectable administration in research models. Most available pharmacokinetic data refer to oral dosing, where the half‑life is described as approximately 24 to 36 hours.
Does LGD-4033 increase bone density in research models?
Yes, LGD‑4033 has been shown to increase bone mineral density in research models. Its effects include stimulating new bone formation, improving bone structure, and reducing bone turnover.
What are the adverse effects of Ligandrol injectables in research?
There are some unwanted effects of LGD‑4033 (Ligandrol) in research models based on preclinical studies. These adverse effects are suppression of testosterone and reductions in endurance performance in test models.
Where can readers find vendor information for LGD-4033 Ligandrol Injectable?
Iron Mountain Labz provides research information and affiliate purchasing pathways but does not directly sell, manufacture, warehouse, or ship LGD-4033 Ligandrol Injectable. Readers should assess third-party suppliers independently and review available identity, purity, and batch-testing documentation.
IML Affiliate Disclosure
Some links on IML may connect readers with third-party suppliers through affiliate arrangements. IML may receive compensation from qualifying transactions at no additional cost to the reader, but the third-party supplier remains responsible for the actual sale, fulfillment, and product documentation.
